Skip to main content
. 2016 Oct 18;9:10.3402/gha.v9.31704. doi: 10.3402/gha.v9.31704

Table 4.

Cost of diabetes in Nepal

Source of cost Study year Study setting Amount (NPR) Amount (US dollar) Reference
Average cost per prescription 2006 Sample frame: outpatient pharmacy (OPP); Urban setting
Sample: 182 DMT2 patients
Study design: cross sectional
1156.2 16.2 (39)
Total cost per visit 2010 Sample frame: A public hospital, a private hospital and two polyclinics one each in Kathmandu and Lalitpur
Sample: 227 DMT2 patients
Study design: cross sectional
NR Mean cost per patient per visit
Public sector: Mean 5.1, SD
253, 95% CI 4.3–5.9
Private sector: Mean 17.5, SD
948.2, CI 15.4–9.6
(47)
Total cost per month 2010 Sample frame: A public hospital, a private hospital and two polyclinics one each in Kathmandu and Lalitpur
Sample: 227 DMT2 patients
Study design: cross sectional
NR Mean cost of illness per patient per month
Mean 40.4, SD 2232.7, 95% CI 36.4–44.5
(47)
Total cost per annum 2010 Sample frame: a public hospital, a private hospital and two polyclinics one each in Kathmandu and Lalitpur
Sample: 227 DMT2 patients
Study design: cross sectional
NR Mean cost per patient per annum
Mean 445.9, SD 27534.9, 95%
CI 396.1–495.6
(47)
Total cost per annum 2002–2003 Sample frame: Two sites in Dhulikhel community and Kathmandu's Diabetes clinic; rural and urban setting
Sample: 60 DMT2 patients
Study design: Prospective observational follow-up
Cost to the health system and the patient per annum 5470 NR (33)

NR=Not Reported.